Helix Biopharma Corp.Helix Biopharma Corp.Helix Biopharma Corp.

Helix Biopharma Corp.

No trades
See on Supercharts

HBPCF fundamentals

An in-depth look to Helix Biopharma Corp. operating, investing, and financing activities

HBPCF free cash flow for Q1 24 is -1.34 M USD. For 2023, HBPCF free cash flow was -4.2 M USD and operating cash flow was -4.19 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Free cash flowYoY growth